Publication | Open Access
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial
13
Citations
33
References
2024
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1